ArticleAmerican journal of hematology2022

Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.

Daniel Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.